| abstract |
The invention relates to novel compounds of formula I wherein M represents hydrogen, or a metal cation, preferably an alkali metal, or alkaline earth metal, is equal to 1, 2 or 3. This invention also comprises compounds of general formula I in their equilibrium forms, including lactone forms, their enantiomers in pure form, or in an enriched form in the optical isomers, racemic mixtures, their diastereomers and solvates. The invention further relates to a process for the preparation of compounds of general formula 1, to pharmaceutical compositions containing compounds of general formula 1 as the sole active ingredient, or in combination with other active principles. A further aspect of the invention is the use of compounds of general formula 1 for the treatment of dyslipidemias, associated or not with other metabolic disorders, such as glucose intolerance syndrome and type 1 or type 2 diabetes mellitus, administered alone or in combination with other substances. |